Stocktoria
BioAtla, Inc. BCAB
Nasdaq · XNAS · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2020-12-16
BioAtla, Inc. statistics & valuation
Market cap$6.1M
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | — | — | — | -32146.7% |
| Net margin | — | — | — | — | -31800.7% |
| Return on assets | -431.1% | -133.1% | -103.2% | -47.2% | -37.5% |
| Return on equity | 164.7% | -489.1% | -174.7% | -59.0% | -45.3% |
| Current ratio | 0.37 | 3.52 | 4.11 | 9.53 | 12.48 |
Source: SEC EDGAR filings · CIK 0001826892 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.